文献速递冠心病

预测阻塞性冠心病存在的临床与生物标志物评分系统

A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

本研究基于前瞻性登记队列,在649例训练队列中从超过200个候选变量(含109个生物标志物)中筛选预测至少1支主要冠状动脉≥70%狭窄的指标,构建临床与生物标志物评分,并在278例验证队列中验证。评分对≥70%狭窄的曲线下面积为0.87,最佳截断点敏感度77%、特异度84%、阳性预测值90%,高评分与随访3.6年时新发急性心肌梗死相关(HR 2.39)。

要点

  • 评分由男性、既往经皮冠状动脉介入治疗及midkine、脂联素、载脂蛋白C-I、肾损伤分子-1组成。
  • 验证队列中评分对≥70%狭窄的AUC为0.87,最佳截断点敏感度77%、特异度84%、阳性预测值90%。
  • 评分升高预测随访3.6年新发急性心肌梗死(HR 2.39)。

核心结论

  • 作者描述了一种对预测解剖学显著冠心病具有高准确性的临床与生物标志物评分。

研究设计与样本

  • 基于因冠状动脉造影转诊患者的前瞻性登记,训练队列649例,验证队列278例。

主要发现

  • 训练队列中评分升高预测所有受试者≥70%狭窄(OR 9.74,p<0.001),男性(OR 7.88,p<0.001),女性(OR 24.8,p<0.001),无既往冠心病者(OR 8.67,p<0.001)。
  • 验证队列中评分对冠状动脉狭窄≥70%的受试者工作特征曲线下面积为0.87(p<0.001)。
  • 评分越高与血管造影狭窄程度越重相关。
  • 最佳截断点时评分对≥70%狭窄的敏感度为77%、特异度为84%、阳性预测值为90%。
  • 将评分分为5个等级可在42%的受试者中以>90%的预测值识别或排除冠心病。

关键数值与推荐

  • 评分包含临床变量(男性、既往经皮冠状动脉介入治疗)和4种生物标志物(midkine、脂联素、载脂蛋白C-I、肾损伤分子-1)。
  • 训练队列从>200个候选变量(包括109个生物标志物)中识别至少1支主要冠状动脉≥70%狭窄的预测因子。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Noninvasive models to predict the presence of coronary artery disease (CAD) may help reduce the societal burden of CAD. OBJECTIVES: From a prospective registry of patients referred for coronary angiography, the goal of this study was to develop a clinical and biomarker score to predict the presence of significant CAD. METHODS: In a training cohort of 649 subjects, predictors of ≥70% stenosis in at least 1 major coronary vessel were identified from >200 candidate variables, including 109 biomarkers. The final model was then validated in a separate cohort (n = 278). RESULTS: The scoring system consisted of clinical variables (male sex and previous percutaneous coronary intervention) and 4 biomarkers (midkine, adiponectin, apolipoprotein C-I, and kidney injury molecule-1). In the training cohort, elevated scores were predictive of ≥70% stenosis in all subjects (odds ratio [OR]: 9.74; p < 0.001), men (OR: 7.88; p <0.001), women (OR: 24.8; p < 0.001), and those with no previous CAD (OR: 8.67; p < 0.001). In the validation cohort, the score had an area under the receiver-operating characteristic curve of 0.87 (p < 0.001) for coronary stenosis ≥70%. Higher scores were associated with greater severity of angiographic stenosis. At optimal cutoff, the score had 77% sensitivity, 84% specificity, and a positive predictive value of 90% for ≥70% stenosis. Partitioning the score into 5 levels allowed for identifying or excluding CAD with >90% predictive value in 42% of subjects. An elevated score predicted incident acute myocardial infarction during 3.6 years of follow up (hazard ratio: 2.39; p < 0.001). CONCLUSIONS: We described a clinical and biomarker score with high accuracy for predicting the presence of anatomically significant CAD. (The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases; NCT00842868).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ibrahim NE, Januzzi JL, Magaret CA, et al. A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease. J Am Coll Cardiol. 2017. PMID: 28254177. doi:10.1016/j.jacc.2016.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。